Synonyms:
Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: FEH7RQ7B3J

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Inactive tyrosine-protein kinase transmembrane receptor ROR1 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Lymphocytic, Chronic, B-Cell 2 D015451 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297728
FDA SRS FEH7RQ7B3J